Papa & Barkley Hires Beauty Industry Leader As New CEO
EUREKA, Calif., – Papa & Barkley, a leading cannabis wellness products company in California, today announced various promotions and additions to its executive team. Evelyn Wang has joined the company as its new Chief Executive Officer. Zeeshan Hyder has joined as Chief Financial Officer.
Adam Grossman, Papa & Barkley’s Founder and Chief Executive Officer, will become Executive Chairman of the Board of Directors, focusing on strategy, geographic expansion, and investor relations. Guy Rocourt, (pictured) Co-Founder and Chief Product Officer was promoted to President in September and will continue in this role, and as the company’s Chief Product Officer, focusing on product development and innovation.
Ms. Wang comes to Papa & Barkley with over 15 years of senior management experience leading premier beauty brands at L’Oreal and The Estee Lauder Companies. Most-recently, she served as Chief Marketing Officer for Milani Cosmetics, a leading international color cosmetics brand. Her expertise building brands and running profitable business units, as well as her leadership of high functioning teams and command of operational levers, position her well to guide Papa & Barkley’s next stage of growth. Ms. Wang has a deep personal commitment to plant-based medicine, wellness and sustainability, core values of Papa & Barkley.
“It has been a tremendous honor to serve as the CEO of Papa & Barkley since founding the company. I am incredibly proud of everything our team has accomplished together in just five years,” said Grossman. “We have earned our position as the top wellness brand in Cannabis – our products truly change people’s lives. The Board and I are confident that Evelyn is the right leader to build on our momentum and brand, adding depth to our stellar executive team. Zeeshan is a tremendous addition as well, bringing strong financial management experience and an extensive knowledge of the cannabis M&A landscape. This is an exciting time for Papa & Barkley.”
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not translate into a boost in licensed retail sales or state tax revenue during the first quarter of 2023. According to ...
C21 Investments Repays $30 Million Debt to CEO Sonny Newman
LOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion of the full repayment of its $30 million senior secured note owed to Sonny Newman, the Company's President and Chief ...